Event ContactsPaid membership required to see this information
ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for four focused meetings that explore the frontiers of immunology as the basis for patient treatment.
Part 1 of the 9th annual "Novel Vaccines" meeting addresses "Adjuvants, TLRs and DNA Vaccines," while Part 2 explores "Emerging Vaccine Technologies." The 2nd annual "Immunomodulatory Therapeutic Antibodies for Cancer" meeting examines developments in the models and tools used in developing these emerging drug products, while the inaugural "Combination Cancer Immunotherapy" meeting focuses on the application of these antibody programs in combination with other treatment modalities. Target Discovery for T Cell Therapy Symposium will bring together leading academic and industry researchers to discuss how to find and validate suitable targets and antigens for t cell therapies.
Exhibitor / Sponsor Information:
CHI offers comprehensive packages that can be customized to your budget and objectives. Sponsorship allows you to achieve your goals before, during, and long after the event. Packages may include presentations, exhibit space and branding, as well as the use of delegate lists. Signing on early will maximize your exposure to qualified decision-makers and drive traffic to your website in the coming months.
Exhibitors will enjoy facilitated networking opportunities with qualified delegates, making it the perfect platform to launch a new product, collect feedback, and generate new leads. Exhibit space sells out quickly, so reserve yours today!
CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and Clinical Informatics News.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
Contact the event managers listed below for more information about how you can participate at the ImVacS: The Immunotherapies and Vaccines Summit.
Event WebsitePaid membership required to see this information
|Conference/Event Dates:||08/11/2014 - 08/14/2014|
|Primary Industry:||Allergy & Clinical Immunology|
|Other Industries:||Allergy & Clinical Immunology, Business, Cancer, Professional Healthcare, Sciences|
|Audience:||ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for four focused meetings that explore the frontiers of immunology as the basis for patient treatment.|
|Venue:||Marriott Long Wharf Hotel|
|Venue Phone:||(617) 227-0800|
|Venue Type:||Indoor - Hotel|
|Official Conference Hotel:||Marriott Long Wharf Hotel|
|Conference Hotel URL:||http://www.marriott.com/hotels/travel/boslw-boston-marriott-long-wharf...|
|Exhibit Floorplan:||Click Here|
|Booth Size||Booth Cost||Available Amenities|
|Booth Space||$3,795||Electricity:||Yes||- Unknown Price|
|Marketing Vehicles Allowed:||Call|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.
- 2014 Floorplan & Exhibitor List: